Go Pro

MarketBeat Instant News Alerts

Docusign logo with Technology background

Insider Selling: Docusign (NASDAQ:DOCU) Director Sells 548 Shares

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Teresa Briggs sold 548 shares of the firm's stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $64.60, for a total transaction of $35,400.80. Following the sale, the director directly owned 10,811 shares of the company's stock, valued at $698,390.60. The trade was a 4.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NASDAQ:DOCU
Read Insider Selling: Docusign (NASDAQ:DOCU) Director Sells 548 Shares
Q2 logo with Technology background

Insider Selling: Q2 (NYSE:QTWO) General Counsel Sells 636 Shares of Stock

Q2 Holdings, Inc. (NYSE:QTWO - Get Free Report) General Counsel Michael Kerr sold 636 shares of the company's stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $60.96, for a total transaction of $38,770.56. Following the completion of the transaction, the general counsel owned 80,739 shares of the company's stock, valued at approximately $4,921,849.44. The trade was a 0.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

NYSE:QTWO
Read Insider Selling: Q2 (NYSE:QTWO) General Counsel Sells 636 Shares of Stock
Edwards Lifesciences logo with Healthcare background

Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares

Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) VP Daniel Lippis sold 619 shares of the company's stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $87.51, for a total value of $54,168.69. Following the completion of the transaction, the vice president owned 40,034 shares in the company, valued at $3,503,375.34. This represents a 1.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE:EW
Read Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares
Aardvark Therapeutics logo with Healthcare background

Aardvark Therapeutics (NASDAQ:AARD) Insider Sells 14,754 Shares of Stock

Aardvark Therapeutics, Inc. (NASDAQ:AARD - Get Free Report) insider Nelson Sun sold 14,754 shares of the firm's stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $5.00, for a total transaction of $73,770.00. Following the completion of the transaction, the insider directly owned 97,475 shares in the company, valued at $487,375. This trade represents a 13.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

NASDAQ:AARD
Read Aardvark Therapeutics (NASDAQ:AARD) Insider Sells 14,754 Shares of Stock
Cytokinetics logo with Healthcare background

Insider Selling: Cytokinetics (NASDAQ:CYTK) Director Sells $74,660.00 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) Director Robert Landry sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $74.66, for a total transaction of $74,660.00. Following the sale, the director owned 9,184 shares of the company's stock, valued at $685,677.44. This represents a 9.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NASDAQ:CYTK
Read Insider Selling: Cytokinetics (NASDAQ:CYTK) Director Sells $74,660.00 in Stock
Snap logo with Communication Services background

Insider Selling: Snap (NYSE:SNAP) CAO Sells 20,000 Shares

Snap Inc. (NYSE:SNAP - Get Free Report) CAO Rebecca Morrow sold 20,000 shares of Snap stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $5.35, for a total value of $107,000.00. Following the sale, the chief accounting officer directly owned 578,105 shares of the company's stock, valued at approximately $3,092,861.75. This trade represents a 3.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

NYSE:SNAP
Read Insider Selling: Snap (NYSE:SNAP) CAO Sells 20,000 Shares

Trending News

All MarketBeat Instant News Alerts

Telos logo with Technology background

Telos (NASDAQ:TLS) EVP Sells $110,246.13 in Stock

NASDAQ:TLS
Read Telos (NASDAQ:TLS) EVP Sells $110,246.13 in Stock
PBF Energy logo with Energy background

PBF Energy (NYSE:PBF) Insider Sells $269,841.62 in Stock

NYSE:PBF
Read PBF Energy (NYSE:PBF) Insider Sells $269,841.62 in Stock
RingCentral logo with Technology background

RingCentral (NYSE:RNG) CAO Tarun Arora Sells 4,172 Shares

NYSE:RNG
Read RingCentral (NYSE:RNG) CAO Tarun Arora Sells 4,172 Shares
Aardvark Therapeutics logo with Healthcare background

Aardvark Therapeutics (NASDAQ:AARD) Insider Nelson Sun Sells 62,000 Shares

NASDAQ:AARD
Read Aardvark Therapeutics (NASDAQ:AARD) Insider Nelson Sun Sells 62,000 Shares
PVH logo with Consumer Discretionary background

Stefan Larsson Acquires 14,179 Shares of PVH (NYSE:PVH) Stock

NYSE:PVH
Read Stefan Larsson Acquires 14,179 Shares of PVH (NYSE:PVH) Stock
Alignment Healthcare logo with Healthcare background

Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 122,707 Shares of Stock

NASDAQ:ALHC
Read Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 122,707 Shares of Stock
Halozyme Therapeutics logo with Healthcare background

Halozyme Therapeutics (NASDAQ:HALO) CEO Helen Torley Sells 20,000 Shares

NASDAQ:HALO
Read Halozyme Therapeutics (NASDAQ:HALO) CEO Helen Torley Sells 20,000 Shares
Halozyme Therapeutics logo with Healthcare background

Helen Torley Sells 20,000 Shares of Halozyme Therapeutics (NASDAQ:HALO) Stock

NASDAQ:HALO
Read Helen Torley Sells 20,000 Shares of Halozyme Therapeutics (NASDAQ:HALO) Stock
Alignment Healthcare logo with Healthcare background

John Kao Sells 172,600 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

NASDAQ:ALHC
Read John Kao Sells 172,600 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock
Docusign logo with Technology background

Peter Solvik Sells 46,000 Shares of Docusign (NASDAQ:DOCU) Stock

NASDAQ:DOCU
Read Peter Solvik Sells 46,000 Shares of Docusign (NASDAQ:DOCU) Stock
Alignment Healthcare logo with Healthcare background

Insider Selling: Alignment Healthcare (NASDAQ:ALHC) CEO Sells 385,270 Shares

NASDAQ:ALHC
Read Insider Selling: Alignment Healthcare (NASDAQ:ALHC) CEO Sells 385,270 Shares
Hinge Health logo with Healthcare background

Hinge Health (NYSE:HNGE) CFO James Budge Sells 55,561 Shares

NYSE:HNGE
Read Hinge Health (NYSE:HNGE) CFO James Budge Sells 55,561 Shares
Warner Bros. Discovery logo with Communication Services background

Warner Bros. Discovery (NASDAQ:WBD) Director Sells $5,646,000.00 in Stock

NASDAQ:WBD
Read Warner Bros. Discovery (NASDAQ:WBD) Director Sells $5,646,000.00 in Stock
Hinge Health logo with Healthcare background

Hinge Health (NYSE:HNGE) CEO Daniel Antonio Perez Sells 150,000 Shares

NYSE:HNGE
Read Hinge Health (NYSE:HNGE) CEO Daniel Antonio Perez Sells 150,000 Shares
PBF Energy logo with Energy background

PBF Energy (NYSE:PBF) Insider Sells $24,561,057.28 in Stock

NYSE:PBF
Read PBF Energy (NYSE:PBF) Insider Sells $24,561,057.28 in Stock
Editas Medicine logo with Healthcare background

Editas Medicine Targets 2026 Patient Dosing for LDL Gene-Editing Therapy

NASDAQ:EDIT
Read Editas Medicine Targets 2026 Patient Dosing for LDL Gene-Editing Therapy
Invitation Home logo with Real Estate background

Invitation Home Announces Quarterly Dividend of $0.30 (NYSE:INVH)

NYSE:INVH
Read Invitation Home Announces Quarterly Dividend of $0.30 (NYSE:INVH)
Dynex Capital logo with Finance background

Dynex Capital, Inc. Announces Monthly Dividend of $0.17 (NYSE:DX)

NYSE:DX
Read Dynex Capital, Inc. Announces Monthly Dividend of $0.17 (NYSE:DX)
ARS Pharmaceuticals logo with Healthcare background

ARS Pharmaceuticals (NASDAQ:SPRY) Sets New 12-Month Low - Should You Sell?

NASDAQ:SPRY
Read ARS Pharmaceuticals (NASDAQ:SPRY) Sets New 12-Month Low - Should You Sell?
Pinterest logo with Communication Services background

Pinterest CEO: AI Shopping Push Drives Gen Z Growth, Ad Gains

NYSE:PINS
Read Pinterest CEO: AI Shopping Push Drives Gen Z Growth, Ad Gains
Tenet Healthcare logo with Healthcare background

Talon Private Wealth LLC Grows Stake in Tenet Healthcare Corporation $THC

NYSE:THC
Read Talon Private Wealth LLC Grows Stake in Tenet Healthcare Corporation $THC
OppFi logo with Finance background

Todd Schwartz Buys 3,350 Shares of OppFi (NYSE:OPFI) Stock

NYSE:OPFI
Read Todd Schwartz Buys 3,350 Shares of OppFi (NYSE:OPFI) Stock

Glass House Brands (NYSE:GLAS) SVP William Tu Sells 3,818 Shares

NYSE:GLAS
Read Glass House Brands (NYSE:GLAS) SVP William Tu Sells 3,818 Shares
Kodiak Gas Services logo with Energy background

William Chad Lenamon Sells 1,000 Shares of Kodiak Gas Services (NYSE:KGS) Stock

NYSE:KGS
Read William Chad Lenamon Sells 1,000 Shares of Kodiak Gas Services (NYSE:KGS) Stock

Featured Articles and Offers

Alert Categories

All Alerts